Interpretation of the risk associated with the unexpected finding of lobular carcinoma in situ

Annals of Surgical Oncology

Volumn 3, Issue 1, 1996, Pages 57-61

  Zurrida, Stefano ^a,d   Bartoli, Cesare ^b   Galimberti, Viviana ^a   Raselli, Roberta ^a   Barletta, Lucilla ^c  

^a Department of Surgical Oncology ^*

^b Division of Diagnostic Oncology and Outpatient Clinic

^c NATIONAL CANCER INSTITUTE   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Invasive breast cancer; Lobular carcinoma in situ; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; FEMALE; FOLLOW UP; HUMAN; LUNG CARCINOMA; MASTECTOMY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029689703     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02409052     Document Type: Article

References (38)

1. Seidman H, Gelb SK, Silverberg E, La Verda N, Lubera JA. Survival experience in the Breast Cancer Detection Demonstration Project. CA 1987;37:258-90.
2. Shapiro S, Venet W, Strax P, Venet L, roeser R. Ten- to fourteen year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;46:1298-303.
3. Tabar L, Fagerberg CJT, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985;1:829-32.
4. Andersen JA, Schiodt T. On the concept of carcinoma in situ of the breast. Pathol Res Pract 1980;166:407-14
5. Farrow JH. Current concepts in the detection and treatment of the earliest of early breast cancer. Cancer 1970;25:468-77.
6. Macanlay RAA, Mitchinson MJ. Lobular carcinoma in situ of the breast. Br J Surg 1973;60:527-9.
7. Warner NE. Lobular carcinoma of the breast. Cancer 1969; 23:840-6.
8. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
9. Veronesi U, Salvadori B, Luini A, et al. Conservative treatment of early breast cancer: long term results of 1232 cases treated with quadrantectomy, axillary dissection and radiotherapy. Ann Surg 1990;211:250-9.
10. World Health Organization. Histological typing of breast tumors. Tumori 1982;68:181-98.
11. Schwartz GF,-Feig SA, Patchefsky AS. Significance and staging of nonpalpable carcinomas of the breast. Surg Gynecol Obstet 1988;166:6-10.
12. Andersen JA, Blichert-Toft M, Dyreborg U. In situ carcinomas of the breast. Types, growth pattern, diagnosis and treatment. Eur J Surg Oncol 1987;13:105-11.
13. Van Dongen JA, Harris JR, Peterse JL, et al. In situ breast cancer: the EORTC consensus meeting. Lancet 1989;2:25-7.
14. Giordano JM, Klopp CT. Lobular carcinoma in situ. Cancer 1973;31:105-9.
15. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Non invasive breast carcinoma. Results of a National Sur-vey by the American College of Surgeons. Ann Surg 1980; 192:139-47.
16. Berrino F, Crosignani P, Gatta G, Macaluso M, Pisani P, Viganò C. Italy Lombard region, Varese Province. In: Muir C, Water-house J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol. 5. IARC Scientific Publication No. 88. Lyon, France: IARC, 1987:560-5.
17. Berry G. The analysis of mortality by the subject-year method. Biometrics 1983;39:173-84.
18. Vineis P, Duca PG, Pasquini P. Manuale di metodologia epidemiologica. Rome: La Nuova Italia Scientifica, 1988:75-9.
19. Fisher B, Slack NH, Bross IDJ, et al. Cancer of the breast: size of neoplasm and prognosis. Cancer 1969;24:1071-80.
20. Fisher B, Bauer M, Wickerman DL, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983;52:1551-7.
21. Veronesi U, Galimberti V, Zurrida S, Merson M, Greco M, Luini A. Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 1993;2:224-8.
22. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 1988;6:1076-87.
23. Silvestrini R, Daidone MG, Gasparini GP. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 1985:56:1982-7.
24. Gallager HS, Martin JE. An orientation to the concept of minimal breast cancer. Cancer 1971;28:1505-7.
25. Hutter RVP, Foote FW. Lobular carcinoma in situ: long term follow up. Cancer 1969;24:1081-5.
26. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr. Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with an average follow up of 24 years. Am J Surg Pathol 1978;2:225-51.
27. Salvadori B, Bartoli C, Zurrida S, et al. Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer 1991;27:35-7.
28. Rosen PP. Lobular carcinoma in situ and intraductal carcinoma of the breast. Monogr Pathol 1984;25:59-105.
29. Balch CM, Ames FC, Bland KI. Clinical decision-making in early breast cancer. Ann Surg 1993;217:207-25.
30. Walt AJ, Simon M, Swanson GM. The continuing dilemma of lobular carcinoma in situ. Arch Surg 1992;127:904-9.
31. Ciatto S, Cataliotti L, Cardona G, Bianchi S, members of the Coordinating Center and Writing of FONCAM (National Task Force for Breast Cancer). Risk of infiltrating breast cancer subsequent to lobular carcinoma in situ. Tumori 1992;78:244-6.
32. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, De Palo AA, Rosen PP. Breast carcinoma in situ. Arch Surg 1989; 124:33-6.
33. Benfield JR, Fingerhut AG, Warner NE. A multidiscipline view of lobular breast carcinoma. Ann Surg 1972;38:115-6.
34. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
35. Lambird PA, Shelly WM. The spatial distribution of lobular in situ mammary carcinoma: implications for size and site of breast biopsy. JAMA 1969;210:689-93.
36. Rosen PP, Braun DW, Lyngholm B, Urban JA, Kinne DW. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer 1981;47:813-9.
37. Frykberg ER, Santiago F, Betsill WL, O'Brien PH. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 1987; 164:285-301.
38. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish 2-county program of mammography screening for breast cancer. Radial Clin North Am 1992; 30:187-210.